News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Pre-Clinical
Spring Bank Pharmaceuticals, Inc. Presents Preclinical And Clinical Data On Immunomodulatory Agent SB 9200 At The 2015 Annual Meeting Of The European Association For The Study Of The Liver 4/27/2015
Posters At ECCMID 2015 Highlight Preclinical Data From Synthetic Biologics' Novel SYN-005 Monoclonal Antibody Combination For The Treatment And Prophylaxis Of Whooping Cough (Pertussis) 4/27/2015
TAXIS Pharmaceuticals, Inc. Demonstrates Clinical Potential Of TXA709 In Combating Antibiotic Resistance 4/27/2015
Novira Therapeutics Announces Presentation Of Preclinical Antiviral Data For NVR 3-778 At EASL 4/27/2015
BioTime (BTX)’s Clinical Grade Stem Cells From Subsidiary ES Cell International To Be Used In Planned CIRM-Funded Preclinical Studies Of Huntington’s Disease 4/27/2015
Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy Of Alvocidib And Bromodomain Protein Inhibitors In Nonclinical Models Of Acute Myeloid Leukemia 4/27/2015
Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression In Models Of Hepatocellular Carcinoma 4/24/2015
AuraSense Therapeutics Announces Publication Of Preclinical Data Demonstrating Immuno-Modulation By Its Proprietary Spherical Nucleic Acid Platform 4/23/2015
Medivir AB (MVRBF): Positive Preclinical Antiviral And Safety Profile Of MIV-802 Supports Continued Development 4/23/2015
Cytori Therapeutics, Inc. (CYTX) Reports Preclinical And Mechanistic Data Supporting Use Of Cytori Cell Therapy In Wounds Combining Thermal Burn And Radiation Exposure 4/23/2015
Glide Technologies Completes Successful Proof-of-Concept Study With Novel Solid Dose Formulation of Teriparatide SDI 4/23/2015
TRANSGENE (ENX:TNG) Presents New Data With TG1050, An Immunotherapy Being Developed To Treat Chronic Hepatitis B, At The International Liver Congress 2015 4/23/2015
Threshold Pharmaceuticals, Inc. (THLD) Reports Preclinical Data Suggesting That TH-4000 May Overcome Resistance To Conventional EGFR Tyrosine Kinase Inhibitors 4/23/2015
PhaseBio Announces Promising Pre-Clinical Results For PB1046 In Models Of Duchenne Muscular Dystrophy 4/22/2015
Capricor Therapeutics, Inc. Granted FDA Orphan Drug Designation For Allogeneic Cardiosphere-Derived Cells For The Treatment Of Duchenne Muscular Dystrophy 4/22/2015
Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline Including Proprietary And Partnered Programs At AACR 2015 Annual Meeting 4/22/2015
Prescient Therapeutics Release: Encouraging Pre-Clinical Data Presented At U.S. Cancer Meeting 4/22/2015
Acetylon Pharmaceuticals Presents Data On Synergistic Activity Of Selective HDAC6 Inhibition In Preclinical Models Of Multiple Myeloma And Mantle Cell Lymphoma At The AACR Annual Meeting 4/22/2015
BIND Therapeutics (BIND) Presents Data Highlighting Ability Of Accurins To Control Biodistribution And Accumulate In Target Tissue At AACR Annual Meeting 2015 4/22/2015
Navidea Biopharmaceuticals (NAVB) Data For Manocept CD206 Targeting Platform Demonstrate Potential To Impact Tumor-Associated Macrophages And Kaposi’s Sarcoma Tumor Cells 4/22/2015
Curis, Inc. (CRIS) Presents Preclinical Data On CUDC-427 At AACR Annual Meeting 4/22/2015
Tekmira (TKMR) And Collaborators Publish Positive Preclinical Ebola Survival Data In Nature Journal 4/22/2015
Immunexcite Presents New Preclinical Data At AACR Demonstrating Ability Of Its Novel Cancer Immunotherapy Approach To Activate A Potent And Precise T-Cell Attack On Tumors 4/21/2015
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data On Clinical And Preclinical Anti-Cancer Stem Cell Programs At AACR Annual Meeting 4/21/2015
Advaxis, Inc. Presents Lm-LLO Cancer Immunotherapy Data at the 2015 AACR Meeting 4/21/2015
Calithera Biosciences, Inc. (CALA) Highlights Results From Six Preclinical Abstracts At The AACR Annual Meeting 2015 4/21/2015
Preclinical Data Presented At AACR Demonstrate Synergistic Anti-Tumor Effects Of Peregrine Pharmaceuticals, Inc. (PPHM)'s Phosphatidylserine (PS)-Targeting Antibodies With Immune Checkpoint Inhibitors In Models Of Melanoma And Breast Cancer 4/21/2015
Vical Incorporated (VICL) Announces Presentation Of Preclinical Data For Congenital CMV DNA Vaccine At International Conference 4/21/2015
TetraLogic Pharmaceuticals (TLOG) Announces Publication Of Two Papers Describing Birinapant's Preclinical Activity In Chronic Hepatitis B 4/21/2015
Cantrixil Highly Successful In Preventing Growth Of Chemo-Resistant Ovarian Cancer 4/21/2015
Blend Therapeutics Presents Preclinical Data For Lead Candidate BTP-114 That Demonstrated Superiority To Cisplatin In Tumor Growth Inhibition 4/21/2015
Blend Therapeutics Presents Preclinical Data For Lead Pentarin™ Program, BTP-277, Demonstrating Specific And Potent Tumor Cell Targeting For Small-Cell Lung Cancer 4/21/2015
Ariad (ARIA) Announces Results Of Preclinical Studies On Brigatinib At The AACR Annual Meeting 4/21/2015
TRANSGENE (ENX:TNG) Presents New Pre-Clinical Data At AACR On (I) The Combination Of TG4010 With Immune Checkpoint Inhibitors; (Ii) TG3003, An Anti-CD115 Monoclonal Antibody 4/21/2015
Epizyme (EPZM) Presents Preclinical Research Providing Deeper Understanding Of Multiple Cancer Targets 4/20/2015
Rexahn Pharmaceuticals, Inc. (RNN) Identifies RX-3117 Biomarker & Presents Data At The 2015 AACR Annual Meeting 4/20/2015
Celldex (CLDX)'s Varlilumab Demonstrates Synergistic Anti-Tumor Activity With PD-1 Signaling Blockade In Preclinical Studies 4/20/2015
TG Therapeutics, Inc. (MHA) Presents Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting 4/20/2015
Imugene Limited (IMU.AX) Release: HER-Vaxx Re-Formulation Shows Dramatic Ten-Fold Increase In Antibodies And Early Onset Of Response; Additional Milestone Met 4/20/2015
Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity Of BLU-285 In Treatment-Resistant GIST And On Novel Cancer Drug Targets 4/20/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting 4/20/2015
NanoViricides, Inc. (NNVC.PK) Reports That Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms In An Animal Model 4/20/2015
AVEO Oncology (AVEO) Announces Presentation Of AV-380 Preclinical Data In Cancer Associated Cachexia At 2015 Annual Meeting Of The AACR 4/20/2015
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) Improves OutcomesFor Pancreatic Ductal Adenocarcinoma In Mouse Models 4/20/2015
Acetylon Pharmaceuticals Announces Preclinical Anti-Cancer Activity Of Selective HDAC1/2 Inhibitors In Neuroblastoma And Acute Myeloid Leukemia 4/20/2015
DelMar Pharmaceuticals Presents Promising Preclinical Data On VAL-083's Potential To Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4/20/2015
Peloton Therapeutics Presents Promising Data On First Inhibitor Of HIF-2a For Renal Cell Carcinoma At 2015 AACR Annual Meeting 4/20/2015
Ligand Pharmaceuticals Inc. (LGND) Partner TG Therapeutics, Inc. (MHA) Presents Positive Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting 4/20/2015
Tokai Pharmaceuticals (TKAI) Announces Preclinical Results From The University of Maryland Showing Galeterone And Analogs Inhibit Pancreatic Cancer Cell Growth 4/20/2015
Mersana Therapeutics' Lead Fleximer Immunoconjugate Demonstrates Potent Activity In Low HER2-Expressing Tumor Models 4/17/2015
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Three Abstracts Accepted For Presentation At American Association for Cancer Research 2015 Annual Meeting 4/16/2015
Debiopharm Announces Results Of 2 Key Oncology Programs At 2015 American Association for Cancer Research Conference 4/16/2015
Cerulean Pharma Inc. (CERU) Announces Three Posters To Be Presented With Preclinical CRLX101 Data At The American Association for Cancer Research Annual Meeting 4/16/2015
Rexahn Pharmaceuticals, Inc. (RNN) To Present Data On RX-3117 And Supinoxin At The 2015 American Association for Cancer Research Annual Meeting 4/13/2015
Alnylam (ALNY) And Collaborators Publish Pre-Clinical Study Results In Nature Medicine On ALN-AT3, An Investigational RNAi Therapeutic Targeting Antithrombin (AT) For The Treatment Of Hemophilia And Rare Bleeding Disorders (RBD) 4/13/2015
Cerulean Pharma Inc. (CERU) Announces Publication Showing CRLX101 Targets Breast Cancer Stem Cells And Impedes Resistance To Anti-Angiogenic Therapy In Preclinical Models 4/13/2015
ChromaDex, Inc. Release: Published Study Shows Topical Treatment With Pterostilbene Effectively Protects Hairless Mice Against UVB Radiation-Induced Skin Damage And Carcinogenesis 4/10/2015
Inovio Pharmaceuticals (INO) HPV Immunotherapy Activates Robust In Vivo T Cell Responses In Head & Neck Cancer Patients 4/9/2015
Anavex (AVXL) Encouraged By New Scientific Data Revealing Positive Role Of Sigma-1 Receptors In Brain Injuries 4/7/2015
Endonovo Therapeutics Targets Non-Invasive Treatment For Acute And Chronic Inflammatory Conditions Of The Liver 4/7/2015
Kite Pharma (KITE) Announces Publication In Science Of Cancer Immunotherapy Articles Authored By Lead Collaborators At The National Cancer Institute And The Netherlands Cancer Institute (NCI) 4/6/2015
Corbus Pharmaceuticals, Inc. Announces Presentation Of Positive Data On Anti-Fibrotic Effects Of Resunab In A Preclinical Model Of Lung Fibrosis At The Experimental Biology 2015 Scientific Conference 4/1/2015
BioBlast Pharma (ORPN) Announces Positive In Vivo Preclinical Proof-Of-Concept Results Of Its Cabaletta Platform In Spinocerebellar Ataxia Type 3 (SCA3) 3/30/2015
Calithera Biosciences, Inc. (CALA) Reports Fourth Quarter And Full Year 2014 Financial Results And Recent Highlights 3/27/2015
BioBlast Pharma (ORPN) Announces Positive Preclinical Proof-Of-Concept Results Of Its Novel Mitochondrial Protein Replacement Platform In Friedreich's Ataxia 3/26/2015
Tekmira (TKMR) Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of Apoc3 And ANGPTL3 Genes 3/26/2015
Genisphere's 3DNA Drug Delivery Platform Achieves Success In Preclinical Treatment Of Posterior Capsular Opacification (PCO) 3/26/2015
Arch Therapeutics Announces Favorable Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device Versus A Popular Cellulose-Based Hemostatic Agent 3/25/2015
AvidBiotics Release: Study Published In mBio Shows That Avidocin Proteins Prevent Clostridium Difficile Infection In Mice Without Harming Protective Gut Bacteria 3/24/2015
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published In The Journal of Urology 3/24/2015
Conatus Pharmaceuticals Inc. And BioReliance Corporation Present Key Emricasan Preclinical Safety Results At Society Of Toxicology Annual Meeting 3/24/2015
Batu Biologics Publishes Preclinical Data For ValloVax 3/20/2015
Kineta Inc.’s SHK-186 Shows Encouraging Early Results As Potential Therapy For Autoimmune Eye Diseases 3/19/2015
Assay Depot, Inc. Creates Preclinical Innovation Marketplace For AstraZeneca PLC (AZN) 3/19/2015
Sangui BioTech International Inc. (SGBI): Series Of Preclinical Trials Concluded Successfully 3/18/2015
Blueprint Medicines Publishes Preclinical Proof-Of-Concept Data On Promising New Therapy For Patients With Genomically Defined Hepatocellular Carcinoma 3/16/2015
Synthetic Biologics Reports Year End 2014 Financial Results And Operational Highlights 3/16/2015
BioLineRx Ltd.’s Treatment for Type 1 Diabetes Effective In Preclinical Trials 3/11/2015
Greenovation Biotech GmbH Successfully Completes Preclinical Toxicology Studies Of Alpha - Galactosidase 3/10/2015
Regeneus (RGS.AX) (ASX:RGS) Positive Preclinical Results For Progenza 3/9/2015
Biothera's Investigational Cancer Immunotherapy Imprime PGG Neutralizes Cancer Defense Mechanisms In The Tumor Mircoenvironment 3/9/2015
Horizon Pharma plc.  (HZNP) Announces That Pre-Clinical Data Show Treatment With Interferon Gamma Improved Signs Of Disease Severity Of Rare Bone Disease 3/9/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015
N8 Medical Release: Recently Published Study Demonstrates That CSA-90 May Promote Osteogenesis And Prevent Staphylococcus Aureus Infection In Preclinical Models 3/4/2015
Sirona Biochem: Positive Preclinical Toxicology Results For Its SGLT2 Inhibitor Trigger Milestone Payment From Wanbang Biopharmaceuticals 3/4/2015
CohBar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-c And Its Role In Metabolic Regulation 3/4/2015
Momenta Pharmaceuticals, Inc. (MNTA) Announces Publication Revealing Development Of A Novel Process To Generate High-Quality Hyper-Sialylated IVIg Drug Candidate In PNAS 3/3/2015
CohBar Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/3/2015
Pharmacyclics (PCYC) Release: In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3/2/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/2/2015
Alkermes plc (ALKS) Announces New Drug Candidate, ALKS 7119, For Treatment Of Alzheimer's Agitation, Depression And Other CNS Diseases 3/2/2015
Gilead (GILD) Announces Preclinical Data For An Investigational TLR7 Agonist In SIV-Infected, Virally Suppressed Monkeys 2/26/2015
Bayer HealthCare (BAY) Strikes Deal With Mission Bay Incubator Tenant Aronora 2/25/2015
Lixte Biotechnology's Lead Compound Reported To Be Active Against Hematologic Cancers In Pre-Clinical Studies 2/25/2015
Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm Therapeutics (KPTI)'s SINE Compounds In The Treatment Of Multiple Sclerosis 2/24/2015
Celsion Corporation (CLSN) Presents Clinical And Preclinical Data For GEN-1 IL-12 Immunotherapy In Ovarian Cancer At The Molecular Medicine TRI-Conference 2/20/2015
Pharmacyte Biotech Initiates Expanded Follow-Up Study In The United States On The Accumulation Of Malignant Ascites Fluid 2/19/2015
Addex Therapeutics (ADXN.SW) mGluR2 NAM Demonstrates Protection In Preclinical Model Of Ischemic Neuronal Death 2/19/2015
Vaccinex, Inc. Announces The Publication Of Data Demonstrating Preclinical Efficacy In An Animal Model Of Huntington Disease 2/18/2015
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015
Anatara Lifesciences Reports Successful DetachTM Trial Results 2/18/2015
Aerie Pharmaceuticals, Inc. (AERI) Announces Potential Breakthroughs With New Preclinical Research 2/18/2015
Halozyme Therapeutics, Inc. (HALO) Announces Preclinical Study Results Of Pegph20 Published In Molecular Cancer Therapeutics 2/17/2015
Tiny Startup Spyryx Looks to One-Up Vertex Pharmaceuticals (MA) (VRTX) With One-Size-Fits-All Cystic Fibrosis Therapy 2/13/2015
Despite CEO's Comments, Experimental Sarepta (SRPT) Drug Protects Lab Monkeys From Ebola 2/11/2015
12635 E. Montview Blvd. Release: Preclinical Melioidosis Results Presented At The 2015 ASM Biodefense And Emerging Diseases Research Meeting In Washington, DC 2/11/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs 2/11/2015
Heat Biologics Presents Positive Preclinical Data On A Novel Approach To Combination Immunotherapy At The Keystone Symposia On Tumor Immunology 2/11/2015
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015 2/10/2015
Amicus Therapeutics, Inc. (FOLD) Presents Preclinical Data On Next-Generation Pompe ERT At Worldsymposium 2015 2/10/2015
Two of Roche (RHHBY)'s Experimental Parkinson's Drugs Caused Lung Toxicity in Monkeys 2/9/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces The Publication Of Preclinical Data For Supinoxin (RX-5902) Demonstrating Mechanism Of Action 2/9/2015
Hemispherx Biopharma (HEB) Posts USAMRIID Ebola Study Concluding Ampligen Produced 100% Survival Rate In Rodents With 100% Mortality In Placebo 2/9/2015
VBL Therapeutics (VBLX) To Present Preclinical Data At Keystone Symposium On Liver Metabolism And Nonalcoholic Fatty Liver Disease 2/9/2015
Lycera Announces Research Showing Promising Anti-Cancer Activity Of Novel, Oral Immunotherapy Candidates 2/9/2015
Anavex (AVXL) Confirms Positive Preclinical Epilepsy Data For ANAVEX 2-73 - Validation As Potential Platform Drug For Multiple Neurodegenerative Diseases 2/9/2015
Hemispherx Biopharma (HEB): US Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate In Ebola Virus Rodent Study 2/2/2015
Pharmacyte Biotech Initiates First Preclinical Study Of Its Encapsulated Cell Product For Novel Treatment Of Diabetes 2/2/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001 1/28/2015
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015
Vaccinex, Inc. Announces Groundbreaking Preclinical Data Demonstrating An Immunomodulatory Role For Anti-SEMA4D Antibody Blockade In Colon And Breast Cancer 1/27/2015
BrainStorm Cell Therapeutics Inc. Announces Exceptional Preclinical Results Of Nurown™ In Mouse Autism Model 1/26/2015
MYOS (MYOS)'s Preclinical Study Of Fortetropin's™ Mechanism Of Action Demonstrate Regulatory Effects On Three Key Muscle Health Pathways 1/26/2015
RestorGenex Announces Presentation Of Scientific Data On RES-529 For The Treatment Of Glioblastoma At Keystone Symposia On PI 3-Kinase Signaling Pathway 1/23/2015
Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences  (NVLT) Fluorescence Cancer-Targeting Agents Chosen For The Cover Of Neurosurgery 1/22/2015
Dry Eye Syndrome: Neuroptis Biotech Successfully Completes The Pre-Clinical Phase For ML7 1/21/2015
PsychoGenics Inc. Obtains A License To The McGill Universityl-R-Thy1-APP Rat Model Of Alzheimer’s Disease 1/21/2015
Karcinolys’ Myb34.5 Oncolytic Virus Preclinical Results In Pancreatic Cancer Featured In Peer-Reviewed Journal "Human Gene Therapy" 1/21/2015
Verastem, Inc. (VSTM) Announces Publication Of Scientific Data For VS-5584 In Cancer Research 1/16/2015
Hemispherx Biopharma (HEB) Release: Low Natural Killer (NK) Activity Observed Across The Chronic Fatigue Syndrome (CFS) Disease Spectrum 1/12/2015
Dicerna Pharmaceuticals (DRNA) Presents Positive Preclinical Data On Its DsiRNA Therapeutics Targeting MYC And ?-Catenin At American Association for Cancer Research MYC: From Biology To Therapy Meeting 1/12/2015
PHARNEXT's Pleotherapy Shows Synergistic Effects With PXT-864 In Alzheimer's Disease Through Preclinical Data Published In Nature's Scientific Reports 1/8/2015
Bio-Path Holdings, Inc. (BPTH)’ Liposomal Grb-2 Featured In Peer-Reviewed Journal “Expert Opinion On Drug Delivery” 1/7/2015
Minerva Neurosciences, Inc. (NERV) Reports Positive Data Showing An Analog Of Minerva's MIN-301 Compound Improves Symptoms Of Parkinson's Disease In Primates 1/6/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces Publication Of Preclinical Data For RX-3117 Demonstrating Effectiveness Against Gemcitabine Resistant Human Cancer Cells 1/6/2015
Novartis AG (NVS) Researchers Claim to Have Discovered "Fountain of Youth" Drug 1/5/2015
Biocryst Pharmaceuticals (BCRX) Announces Study Results For BCX4430 In A Non-Human Primate Model Of Ebola Virus Infection 12/23/2014
Bio-Path Holdings, Inc. (BPTH) To Initiate Development Of Liposomal Bcl-2 In Follicular Lymphoma 12/22/2014
Medivir AB (MVRBF): MIV-802 Has Been Selected As A Candidate Drug And Enters Non-Clinical Development For The Treatment Of Hepatitis C Infection 12/22/2014
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014
Canopus BioPharma, Inc. Announces Positive Results From An In-Vitro Live Ebola Virus Study 12/19/2014
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs 12/16/2014
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014
Vaccinex, Inc. Announces Publication Of Preclinical Studies With An Anti-SEMA4D Antibody In Animal Models Of Neuroinflammatory And Demyelinating Disease 12/12/2014
Enzyme Bio-Systems Ltd. Release: Preclinical Xenograft Studies Show Positive Results For Amooranin 12/11/2014
Syros Pharmaceuticals Announces New Research Published On CDK7 In Lung And Pediatric Cancers 12/11/2014
NIH Publishes Results Of Preclinical Collaboration With ChromaDex, Inc. Showing Potential Benefit Of Nicotinamide Riboside 12/10/2014
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014
Kadmon Corporation Presents Preclinical Data On KD025 In Chronic Graft-Versus-Host-Disease At American Society of Hematology Annual Meeting 12/10/2014
Aptose Biosciences Presents APTO-253 Preclinical Data At 56th American Society of Hematology Annual Meeting 12/9/2014
Fate Therapeutics (FATE) Highlights Effects Of Nutrient-Rich Media On Ex Vivo Programmed CD34+ Cells Sourced From Umbilical Cord Blood 12/9/2014
GlycoMimetics, Inc. (GLYC) Highlights Potential Therapeutic Benefits Of Its Novel E-Selectin Antagonist At 56th American Society of Hematology Annual Meeting 12/9/2014
Epizyme (EPZM) First-In-Class PRMT5 Inhibitor Demonstrates In Vitro And In Vivo Activity In Models Of Mantle Cell Lymphoma 12/9/2014
Fate Therapeutics (FATE) Unveils Preclinical Findings Of Newly-Identified Small Molecule Modulator Combination For Ex Vivo Programming Of Mobilized Peripheral Blood 12/8/2014
Blueprint Medicines Debuts Comprehensive Preclinical Data Set On First Selective Drug For Patients With Systemic Mastocytosis At 2014 American Society of Hematology Annual Meeting 12/8/2014
Geron Corporation (GERN) Announces Publication Of Preclinical Data On Imetelstat Activity In Acute Myelogenous Leukemia 12/8/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Aduro Biotech Announces Preclinical Data Presented At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/4/2014
Xenetic Biosciences Announces OncoHist™ Preclinical Data To Be Featured In A Poster Presentation At The American Society of Hematology Annual Meeting 12/4/2014
ARMGO Pharma Inc. And Servier Announce Advancement Of Rycal ARM210/S48168 Into Clinical Stage Program Targeting Duchenne Muscular Dystrophy 12/4/2014
ZIOPHARM Oncology, Inc. (ZIOP.OB) And Intrexon Corporation Present Clinical And Preclinical Data From Immuno-Oncology Programs At Intrexon Corporation Tumor Immunology And Immunotherapy Meeting 12/4/2014
Idera Pharmaceuticals, Inc. (IDRA) Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent And Systemic Anti-Tumor Activity In Preclinical Models 12/3/2014
Preclinical Data Published On AM-Pharma Holding BV’s recAP To Treat Ultra Rare Disease Hypophosphatasia 12/2/2014
AB Science (AB.PA) Advances Ultra-Selective SYK Kinase Inhibitor Into Full Preclinical Development 12/1/2014
Antibe Therapeutics Inc. Provides Update On Its Acute Pain Drug ATB-352 11/25/2014
Luoxis Announces Presentation Of Multiple Studies Validating Redoxsys As A Rapid And Non-Invasive Means Of Assessing Oxidative Stress 11/24/2014
Inovio Pharmaceuticals (INO) Melanoma DNA Immunotherapy Inhibits Tumor Growth And Increases Survival In Preclinical Study 11/20/2014
Nektar Therapeutics (CA) (NKTR) Presents Preclinical Study Findings For Etirinotecan Pegol (NKTR-102) In Combination With A PARP Inhibitor In BRCA1-Deficient Cancer Model 11/20/2014
Kolltan Pharmaceuticals Inc. Presents KTN3379 Clinical And Preclinical Data At International Cancer Meeting 11/20/2014
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-2701), An Advanced Multi-Targeted Kinase Inhibitor, At 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014
Cardioxyl Pharmaceuticals HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction 11/20/2014
Nuvilex (NVLX) Announces Preliminary Data From Preclinical Study of Effects of Its Pancreatic Cancer Treatment on Ascites Fluid Formation 11/19/2014
Kadmon Corporation Presents Preclinical Data On Bi-Functional Anti-PD-L1/IL-15 Fusion Protein At EORTC-NCI-AACR Symposium 11/19/2014
Arch Therapeutics Reports Positive Preclinical Data From Study of AC5 Surgical Hemostatic Device™ In Animals Treated With Brilinta® (ticagrelor) 11/18/2014
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data On RNAi Therapeutic Programs For Cardio-Metabolic Diseases At American Heart Association Scientific Sessions 2014 11/18/2014
Regulus Therapeutics, Inc. (RGLS) And Sanofi (SAN.PA) Present New Data Enhancing The Preclinical Profile Of RG-012, An Anti-Mir Targeting Microrna-21 For The Treatment Of Renal Dysfunction In Alport Syndrome Patients, At ASN's Kidney Week 2014 Meeting 11/17/2014
Enzyme Bio-Systems Ltd. Announces An Independent Research Group Reported Breast Cancer Preventive Efficacy For A Novel Synthetic Triterpenoid 11/17/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
AstraZeneca PLC (AZN) To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta 11/13/2014
AstraZeneca PLC (AZN) Announces Initiation of Development Program For BRILINTA (ticagrelor) Reversal Agent 11/13/2014
AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting 11/13/2014
Cortice Biosciences Announces Results From Studies Evaluating Pipeline Candidates TPI 287 And CRT 001 In Preclinical Models Of Tauopathies And Alzheimer's Disease 11/12/2014
Preclinical Data For GenVec Inc. (GNVC)'s RSV Vaccine Candidate Presented At The 9th RSV Symposium 11/11/2014
SanguiBioTech GmbH: Preclinical Trials Demonstrate: Sangui Hemoglobin Preparation Improves Oxygen Supply Of Vital Organs 11/11/2014
TetraLogic Pharmaceuticals (TLOG) Announces Results Of Preclinical Studies In Hepatitis B 11/10/2014
Ablynx (ABLYF) To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, Alx-0171, At 9th International Respiratory Syncytial Virus Symposium 11/6/2014
Xencor Provides Data Updates On XmAb Bispecific Antibody Programs And Announces Presentations At Upcoming American Society of Hematology 2014 Annual Meeting 11/6/2014
Innovimmune Biotherapeutics, Inc. To Present Superior Preclinical Therapeutic Efficacy Results In Rheumatoid Arthritis Of Its INV-17 ROR Gamma T Inhibitor Program At The 2014 American College of Rheumatology Annual Meeting 11/5/2014
Innate Pharma (IPH.PA ) : IPH4102 Preclinical Data Published In "Cancer Research" 11/3/2014
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014
Loxo Oncology (LOXO) To Present Pre-Clinical Data On LOXO-101 At Upcoming European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 10/30/2014
CytRx Corporation (CYTR) Announces Publication Of Preclinical Glioblastoma Data In Neoplasia 10/29/2014
Celsion Corporation (CLSN) Presents Preclinical Data For Its TheraSilence™ Platform At The miRNA World Conference Workshop On miRNA Delivery 10/29/2014
FDA Grants Kamada Ltd. (KMDA) Orphan Drug Designation For The Treatment Of Graft Versus Host Disease 10/29/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure 10/27/2014
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses 10/22/2014
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies 10/22/2014
Immunovaccine Inc. Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine 10/21/2014
Omeros Corporation (OMER) Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday 10/21/2014



//-->